The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis

Clinical and Experimental Immunology

Volumn 118, Issue 2, 1999, Pages 268-270

  Verdrengh, M ^a   Kum, K ^b   Chow, A ^b   Tarkowski, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antibody; Arthritis; Staphylococcus aureus; TSST 1

Indexed keywords

MONOCLONAL ANTIBODY; STAPHYLOCOCCUS TOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL VIRULENCE; BINDING SITE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME; TOXIN STRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ARTHRITIS, INFECTIOUS; BACTERIAL TOXINS; CELL DIVISION; CELLS, CULTURED; ENTEROTOXINS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED STRAINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 0032707328     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01061.x     Document Type: Article

References (15)

1. 1 Abdelnour A, Bremell T, Tarkowski A. Toxic shock syndrome toxin-1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis 1994; 170:84-89.
2. 2 Blanco L, Choi M, Conolly K et al. Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun 1990; 58:3020-8.
3. 3 Prasad G, Earhart C, Murray D et al. Structure of toxic shock syndrome toxin I. Biochemistry 1993; 32:13761-6.
4. 4 Bremell T, Lange S, Svensson L et al. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990; 33:1739-44.
5. 5 Bremell T, Abdelnour A, Tarkowski A. Histopathological and serological progression of Staphylococcus aureus arthritis. Infect Immun 1992; 60:2976-85.
6. 6 Abdelnour A, Bremell T, Holmdahl R et al. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur J Immunol 1994; 24:1161-6.
7. 7 Mancini G, Carbonara O, Heremans J. Immunochemical quantitation of antigens by a single radial immunodiffusion. Immunochemistry 1965; 2:235-54.
8. 8 Shimonkevitz R, Boen E, Malmstrom S et al. Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1. Infect Immun 1996; 64:1133-9.
9. 9 Kum WWS, Laupland KB, Chow AW. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, cytokine secretion and lethality. In press.
10. 10 Abdelnour A, Arvidson S, Bremell T et al. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993; 61:3879-85.
11. 11 Jonsson R, Karlsson AL, Holmdahl R. Demonstration of immunoreactive sites on cartilage after in vivo administration of biotinylated antitype II collagen antibodies. J Histochem Cytochem 1989; 37:265-8.
12. 12 Holmdahl R, Mo JA, Jonsson R et al. Multiple epitopes on cartilage type II collagen are accessible for antibody binding in vivo. Autoimmunity 1991; 10:27-34.
13. 13 Tarkowski A, Wagner H, Arthritis and sepsis caused by Staphylococcus aureus: can the tissue injury be reduced by modulating the host's immune system? Mol Med Today 1998; 4:15-18.
14. 14 Newell MK, Hofer RD, Duke R et al. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis. Proc Natl Acad Sci USA 1996; 93:5425-30.
15. 15 Zhao Y, Abdelnour A, Holmdahl R et al. Mice with the xid B-cell defect are less susceptible to developing Staphylococcus aureus induced arthritis. J Imnumol 1995; 155:2067-76.